The mother of one of your patients comes urgently into your clinic after the acute onset of severe pain involving the middle ...

The FDA has issued a complete response letter to Replimune indicating it is unable to approve the biologics license ...

For the first time in more than a decade, the Infectious Diseases Society of America updated its guidelines for complicated ...

A functional precision medicine platform intends to streamline cancer treatment by matching patients against a battery of FDA ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

CMS issued the 2026 Medicare Physician Fee Schedule, or PFS, proposed rule on July 14.It includes a 0.75% increase to the ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Let’s talk about sex.An online survey of more than 1,700 breast cancer survivors showed that most respondents experienced ...

In 2008, the U.S. House of Representatives designated July as Bebe Moore Campbell National Minority Mental Health Awareness ...

The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...

An oral neutrophil modulator appeared safe and demonstrated signals of efficacy in patients with moderate to severe ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of dopaminergic neurons in the substantia nigra is well recognized and drives ...